Skip to main content

Table 4 Characteristics of Optimal (for ETSL) Design Assuming Misspecification of Accrual

From: Design of Phase II cancer trials evaluating survival probabilities

 

Scenario 1*

Scenario 2*

Scenario 3*

Actual/Anticipated Accrual

α

1-β

α

1 - β

α

1 - β

0.25

.1

.512

.070

.687

.109

.924

0.50

.1

.711

.082

.800

.106

.918

1.00

.1

.900

.100

.900

.100

.900

1.50

.1

.963

.114

.934

.092

.863

2.00

.1

.986

.115

.970

.079

.779

  1. * Scenario 1 – Analysis at t 1 and MTSL ; Scenario 2 – Analysis at t 1 and one year after t 1 or one year after accruing n patients, whichever is later; Scenario 3 – Analysis after accrual of n 1 patients and one year after accruing n patients.
Back to article page

BMC Medical Research Methodology

ISSN: 1471-2288

Contact us